Vital Farms Inc (VITL)
Official siteCONSUMER DEFENSIVE • FARM PRODUCTS • NASDAQ
Market Cap: $389.43M
Last updated: Nov 17, 2026 at 11:05 AM ET
Vital Farms Inc (VITL) Stock Forecast
Analysts expect Vital Farms (VITL) to earn -$0.77 per share in the fiscal year ending Dec 31, 2026, on revenue of $729.44M. Of 10 analysts, 4 rate the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Hold. For the fiscal year ending Dec 31, 2027, the EPS consensus is $0.06.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.50, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 40% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 10.0% |
| Buy | 3 | 30.0% |
| Hold | 6 | 60.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 10
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 5.0%.
- Fiscal year ending Dec 31, 2026
- -$0.77
- EPS consensus, revenue $729.44M
- Fiscal year ending Dec 31, 2027
- $0.06
- EPS consensus, revenue $766.01M
- Next report
- Feb 24, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.77 | -$0.97 to -$0.70 | 5 | $729.44M | $727.50M to $730.35M | 10 |
| Dec 31, 2027 | $0.06 | -$0.29 to $0.25 | 5 | $766.01M | $750.00M to $802.00M | 10 |
Quarterly Estimates
The EPS consensus rises from -$0.09 for the quarter ending Dec 31, 2026 to -$0.06 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.09 | -$0.14 to -$0.06 | 12 | $198.93M | $188.36M to $214.20M | 12 |
| Mar 31, 2027 | -$0.06 | -$0.09 to -$0.02 | 2 | $180.90M | $170.00M to $195.50M | 7 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.45.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.77 | -$0.38 | -$0.41 | -$0.41 | -$0.45 | N/A |
| Fiscal year ending Dec 31, 2027 | $0.06 | $0.30 | $0.27 | $0.26 | $0.40 | -85.3% |
| Quarter ending Mar 31, 2027 | -$0.06 | -$0.04 | -$0.04 | -$0.04 | $0.04 | N/A |
Frequently Asked Questions About VITL
What is the VITL stock forecast?
Consensus analyst estimates put Vital Farms's EPS at -$0.77 for the fiscal year ending Dec 31, 2026, on revenue of $729.44M. The consensus rating from 10 analysts is Hold.
How do analysts rate VITL stock?
Of 10 analysts covering Vital Farms, 1 rates it Strong Buy, 3 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from VITL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.77, with estimates from -$0.97 to -$0.70 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.06, with estimates from -$0.29 to $0.25 from 5 analysts.
What revenue do analysts expect from Vital Farms next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $729.44M, with estimates from $727.50M to $730.35M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $766.01M, with estimates from $750.00M to $802.00M.
How many analysts cover VITL?
10 analysts rate Vital Farms stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
VITL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors